These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10915765)

  • 21. CELF proteins regulate CFTR pre-mRNA splicing: essential role of the divergent domain of ETR-3.
    Dujardin G; Buratti E; Charlet-Berguerand N; Martins de Araujo M; Mbopda A; Le Jossic-Corcos C; Pagani F; Ferec C; Corcos L
    Nucleic Acids Res; 2010 Nov; 38(20):7273-85. PubMed ID: 20631008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.
    Zerbe LK; Pino I; Pio R; Cosper PF; Dwyer-Nield LD; Meyer AM; Port JD; Montuenga LM; Malkinson AM
    Mol Carcinog; 2004 Dec; 41(4):187-96. PubMed ID: 15390079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.
    Buratti E; Dörk T; Zuccato E; Pagani F; Romano M; Baralle FE
    EMBO J; 2001 Apr; 20(7):1774-84. PubMed ID: 11285240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
    Kerem E
    Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A-->G, 2751+2T-->A, 296+1G-->C, 1717-9T-->C-D565G) and one nonsense mutation (E822X) in the CFTR gene.
    Tzetis M; Efthymiadou A; Doudounakis S; Kanavakis E
    Hum Genet; 2001 Dec; 109(6):592-601. PubMed ID: 11810271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides.
    Igreja S; Clarke LA; Botelho HM; Marques L; Amaral MD
    Hum Mutat; 2016 Feb; 37(2):209-15. PubMed ID: 26553470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of DAZAP1 and hnRNPA1/A2 to an exonic splicing silencer in a natural BRCA1 exon 18 mutant.
    Goina E; Skoko N; Pagani F
    Mol Cell Biol; 2008 Jun; 28(11):3850-60. PubMed ID: 18391021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing.
    Caputi M; Mayeda A; Krainer AR; Zahler AM
    EMBO J; 1999 Jul; 18(14):4060-7. PubMed ID: 10406810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatio-temporal expression of the trans-acting splicing factors SF2/ASF and heterogeneous ribonuclear proteins A1/A1B in the myometrium of the pregnant human uterus: a molecular mechanism for regulating regional protein isoform expression in vivo.
    Pollard AJ; Sparey C; Robson SC; Krainer AR; Europe-Finner GN
    J Clin Endocrinol Metab; 2000 May; 85(5):1928-36. PubMed ID: 10843177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation.
    Nissim-Rafinia M; Aviram M; Randell SH; Shushi L; Ozeri E; Chiba-Falek O; Eidelman O; Pollard HB; Yankaskas JR; Kerem B
    EMBO Rep; 2004 Nov; 5(11):1071-7. PubMed ID: 15472711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element.
    Pagani F; Buratti E; Stuani C; Romano M; Zuccato E; Niksic M; Giglio L; Faraguna D; Baralle FE
    J Biol Chem; 2000 Jul; 275(28):21041-7. PubMed ID: 10766763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The MKK(3/6)-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation.
    van der Houven van Oordt W; Diaz-Meco MT; Lozano J; Krainer AR; Moscat J; Cáceres JF
    J Cell Biol; 2000 Apr; 149(2):307-16. PubMed ID: 10769024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined computational-experimental analyses of CFTR exon strength uncover predictability of exon-skipping level.
    Aissat A; de Becdelièvre A; Golmard L; Vasseur C; Costa C; Chaoui A; Martin N; Costes B; Goossens M; Girodon E; Fanen P; Hinzpeter A
    Hum Mutat; 2013 Jun; 34(6):873-81. PubMed ID: 23420618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation.
    Lemaire R; Winne A; Sarkissian M; Lafyatis R
    Eur J Immunol; 1999 Mar; 29(3):823-37. PubMed ID: 10092085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas.
    Ghigna C; Moroni M; Porta C; Riva S; Biamonti G
    Cancer Res; 1998 Dec; 58(24):5818-24. PubMed ID: 9865741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable levels of normal RNA in different fetal organs carrying a cystic fibrosis transmembrane conductance regulator splicing mutation.
    Chiba-Falek O; Parad RB; Kerem E; Kerem B
    Am J Respir Crit Care Med; 1999 Jun; 159(6):1998-2002. PubMed ID: 10351951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways.
    Matter N; Marx M; Weg-Remers S; Ponta H; Herrlich P; König H
    J Biol Chem; 2000 Nov; 275(45):35353-60. PubMed ID: 10958793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A missense cystic fibrosis transmembrane conductance regulator mutation with variable phenotype.
    Kerem E; Nissim-Rafinia M; Argaman Z; Augarten A; Bentur L; Klar A; Yahav Y; Szeinberg A; Hiba O; Branski D; Corey M; Kerem B
    Pediatrics; 1997 Sep; 100(3):E5. PubMed ID: 9271620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A highly stable duplex structure sequesters the 5' splice site region of hnRNP A1 alternative exon 7B.
    Blanchette M; Chabot B
    RNA; 1997 Apr; 3(4):405-19. PubMed ID: 9085847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient polyadenylation of Rous sarcoma virus RNA requires the negative regulator of splicing element.
    Fogel BL; McNally LM; McNally MT
    Nucleic Acids Res; 2002 Feb; 30(3):810-7. PubMed ID: 11809895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.